The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHargreaves Lansdown Regulatory News (HL.)

Share Price Information for Hargreaves Lansdown (HL.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 812.00
Bid: 814.20
Ask: 817.80
Change: 3.60 (0.45%)
Spread: 3.60 (0.442%)
Open: 812.00
High: 836.60
Low: 811.80
Prev. Close: 808.40
HL. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

28 Mar 2014 16:11

RNS Number : 5009D
Hargreaves Lansdown PLC
28 March 2014
 



Hargreaves Lansdown plc ("the Company")

Director and PDMR Shareholdings

28 March 2014

 

Notification of Transaction of Directors, Persons Discharging Managerial Responsibility ("PDMR") or Connected Persons in accordance with Disclosure Rules 3.1.4R(1)(a).

Approved share option exercises

 

The Company announces the following Director and PDMRs of the Company have advised that they have exercised an option to purchase ordinary shares of 0.4p each in the Company ("Ordinary Shares") under the Company's Approved Executive Share Option Plan ("Approved scheme"). The exercise price was £1.95 per Ordinary Share and the options were originally granted on 24th March 2009 pursuant to the Hargreaves Lansdown Approved Executive Share Option Plan 2000.

 

Director

Position

Date of exercise

Number of shares over which option exercised

Resultant shareholding (excluding any other share options and including connected persons)

Total percentage shareholding (excluding options)

Mrs Tracey Taylor

Director

27.3.14

15,355

763,369

0.16%

Mr Mark Dampier

PDMR

27.3.14

15,355

814,617

0.17%

Mr Nigel Bence

PDMR

27.3.14

15,355

204,473

0.04%

 

The Ordinary Shares issued in respect of this exercise of options have been satisfied by way of transfer of Ordinary Shares from the Company's Employee Benefit Trust.

 

The Approved scheme exercises above are part of a larger employee exercise which has taken place from 24th March 2014. A total of 43 employees (including directors and PDMRs) were granted options under the scheme.

 

Share sales

 

The Company announces that it has today received notification of transactions from the following PDMRs and Director:

 

 

1) Mr Evans, a Director, sold a total of 7,500 ordinary shares in the Company at a price of £14.68 per share, on the 27th March 2014. The number of ordinary shares sold represented 0.0016% of the ordinary shares in issue. Following this transaction, the beneficial shareholding of Mr Evans (including his connected persons) is 8,125 ordinary shares representing 0.002% of the ordinary shares in issue.

 

2) Mr Hunter, a PDMR, sold a total of 750 ordinary shares in the Company at a price of £14.56 per share, on the 27th March 2014. The number of ordinary shares sold represented 0.0002% of the ordinary shares in issue. Following this transaction, the beneficial shareholding of Mr Hunter (including his connected persons) is 571,521 ordinary shares representing 0.12% of the ordinary shares in issue.

 

3) Mr Bence, a PDMR, sold a total of 2,016 ordinary shares in the Company at a price of £14.63 per share, on the 27th March 2014. The number of ordinary shares sold represented 0.0004% of the ordinary shares in issue. Following this transaction (and the exercise of the approved option detailed above), the beneficial shareholding of Nigel Bence (including his connected persons) is 202,457 ordinary shares representing 0.04% of the ordinary shares in issue.

 

 

Hargreaves Lansdown (Nominees) Limited is the registered shareholder as nominee for the above Directors and PDMRs.

 

For further information contact:

 

Judy Matthews

Company Secretary

Hargreaves Lansdown

0117 9809989

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQVLFLZXFBBBK
Date   Source Headline
1st May 20249:27 amRNSDirector Declaration
30th Apr 20247:00 amRNSTrading Statement
25th Apr 20242:43 pmRNSDirector Declaration
19th Apr 20241:56 pmRNSDirector/PDMR Shareholding
4th Apr 202411:24 amRNSDirector/PDMR Shareholding
7th Mar 20241:54 pmRNSDirector/PDMR Shareholding
28th Feb 20244:01 pmRNSDirector/PDMR Shareholding
27th Feb 20242:29 pmRNSDirector/PDMR Shareholding
26th Feb 20244:43 pmRNSDirector/PDMR Shareholding
23rd Feb 20244:05 pmRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSHalf-year Report
9th Feb 202412:10 pmRNSNotice of Results
6th Feb 202412:08 pmRNSDirectorate Change
1st Feb 20247:09 amRNSDirector Declaration
17th Jan 202412:03 pmRNSDirector Declaration
2nd Jan 202410:06 amRNSDirector Declaration
20th Dec 202312:50 pmRNSDirector/PDMR Shareholding
14th Dec 202312:06 pmRNSDirector Declaration
11th Dec 20237:17 amRNSDirector Declaration
8th Dec 20234:33 pmRNSResult of AGM
6th Dec 20238:10 amRNSDirector Declaration
29th Nov 20237:00 amRNSDirectorate Change
7th Nov 20231:54 pmRNSNotice of AGM
23rd Oct 20238:00 amRNSAnnual Financial Report
19th Oct 20237:00 amRNSTrading Statement
12th Oct 20234:10 pmRNSDirector/PDMR Shareholding
12th Oct 20234:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20233:21 pmRNSDirector/PDMR Shareholding
21st Sep 20234:15 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFinal Results
1st Sep 20239:59 amRNSNotice of Results
19th Jul 20237:00 amRNSTrading Statement
17th Jul 20234:32 pmRNSDirectorate Change
10th Jul 202311:00 amRNSDirectorate Change
15th Jun 202312:13 pmRNSHolding(s) in Company
13th Jun 20231:00 pmRNSDirectorate Change
15th May 20234:51 pmRNSDirector/PDMR Shareholding
10th May 20234:01 pmRNSDirector/PDMR Shareholding
4th May 202311:00 amRNSDirector Declaration
4th May 20237:00 amRNSTrading Statement
25th Apr 20232:13 pmRNSDirector/PDMR Shareholding
1st Mar 202310:22 amRNSDirector/PDMR Shareholding
15th Feb 20237:00 amRNSHalf-year Report
27th Jan 202312:02 pmRNSDirector Declaration
23rd Jan 202310:10 amRNSNotice of Results
19th Jan 20233:33 pmRNSHolding(s) in Company
20th Dec 20222:01 pmRNSDirector/PDMR Shareholding
16th Dec 202211:05 amRNSDirector Declaration
8th Dec 20228:00 amRNSDirectorate Change
24th Oct 20223:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.